Another study has found downregulation of glucose transporter GLUT2 expression and reduced ATP generation in HNF1A-MODY patient iPS-derived β-cells with heterozygous mutation (+/H126D) in comparison to control wild type lines of a different genetic background48. The gene discussed is SLC2A2; the disease is MODY.